We considered 146 β-TM patients (87 females, 38.7 ± 11.1 years), consecutively enrolled in the Extension-Myocardial Iron Overload in Thalassaemia (E-MIOT) project, an Italian network constituted by 66 thalassaemia centres and 11 validated CMR sites [8, 24, 25] sharing clinical data.

The study complied with the Declaration of Helsinki and was approved by the local ethical committee. All patients gave written informed consent.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.